Educational draft · awaiting clinical reviewThe full textbook explains uncertainty but does not replace live national or local guidance, specialist advice, or current prescribing information.
Antenatal depression and anxiety
Psychiatry · UK scope · Sources checked 27 Aug 2026 · Clinical review pending
!
Antenatal mental-health crisis
Suicidal intent, severe self-neglect, psychosis, mania, catatonia, dangerous substance use, inability to eat or drink, or risk from domestic abuse requires urgent assessment; obstetric symptoms such as heavy bleeding, collapse, severe headache or reduced fetal movement need the appropriate maternity emergency pathway in parallel.
Action: Establish immediate safety, gestation, location and support; ask directly about suicide, harm, psychosis, abuse and fetal concerns; arrange same-day mental-health or emergency assessment, contact maternity triage for obstetric danger, and do not leave the person alone when imminent harm is plausible.
Overview
Identify depression and the full range of anxiety disorders during pregnancy, formulate obstetric and psychosocial context, assess safety, and sequence timely psychological and pharmacological care through shared decision-making.
Pregnancy changes context more reliably than it changes the core diagnostic requirements for depression or anxiety. Low mood, loss of pleasure, guilt, hopelessness, psychomotor change and suicidal thinking remain important, but nausea, sleep disruption, appetite change and fatigue overlap with ordinary pregnancy and medical illness. Diagnose from the pattern, persistence, distress, impairment and cognitive-emotional features rather than counting somatic symptoms in isolation.
Anxiety needs diagnostic resolution. Generalised anxiety produces broad, hard-to-control worry; panic brings abrupt surges of fear and bodily arousal; obsessive-compulsive disorder involves intrusive thoughts or images and neutralising rituals; PTSD follows trauma with re-experiencing, avoidance and threat; social anxiety centres on scrutiny; and tokophobia is an extreme fear of childbirth. Intrusive unwanted harm images with preserved insight can occur in OCD and do not by themselves show intent, but every disclosure still requires careful assessment of meaning, control, avoidance, distress and safety.
Practice
Two practice questions
Your practice draft is saved in this browser.
Question 1 of 2
0 correct
PsychiatryOriginal SBA
Moderate antenatal depression
A pregnant adult has moderate depression without psychosis or immediate suicide risk and wants to understand evidence-based initial options. Which discussion best reflects NICE guidance?
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources
Sources and review status
National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.
At booking, first primary-care contact and the early postnatal period, NICE supports two depression identification questions and GAD-2 within a broader discussion. A positive depression response may lead to EPDS or PHQ-9 as part of full assessment or referral. A GAD-2 score of three or more may lead to GAD-7 or referral; a lower score does not end enquiry when avoidance or clinical concern remains. Scores support detection and monitoring but cannot establish diagnosis, capacity, parenting ability or future suicide.
Formulation spans pregnancy intention, trimester, previous losses, fetal or maternal complications, past psychiatric episodes, family history, treatment response, physical disease, sleep, nutrition, alcohol or drug use, housing, finances, relationships and discrimination. Offer private time and ask about domestic abuse in a way that does not increase danger. Determine whether the person can attend appointments, take medication safely and meet basic needs. Ask about mania and hypomania before prescribing an antidepressant.
Treatment is stepped but not mechanically score-driven. Persistent subthreshold symptoms or mild-to-moderate depression can receive facilitated self-help. A history of severe depression changes the threshold for considering an antidepressant even with a mild current episode. For moderate or severe depression, NICE options include high-intensity psychological intervention such as CBT, an antidepressant when risks are understood and it is preferred or therapy is declined or ineffective, and combined treatment after limited response to either alone. For anxiety, use the disorder-specific NICE pathway; PTSD and social anxiety warrant high-intensity psychological intervention initially.
Medication decisions compare illness and treatment harms over time. Consider prior benefit, relapse after stopping, trimester, comorbidity, interactions, neonatal adaptation and the small postpartum-haemorrhage signal when an SSRI or SNRI is used in the month before birth. Avoid abrupt cessation and avoid deliberately ineffective doses. If a new drug is chosen, use an established adult regimen with close early review, and inform maternity and neonatal teams about late-pregnancy exposure rather than routinely tapering a successful antidepressant near delivery.
Access speed matters. NICE states that a person referred with a known or suspected mental-health problem in pregnancy or the postnatal period should be assessed for treatment within two weeks and receive psychological intervention within one month of initial assessment. Severe symptoms, active risk or bipolar-spectrum features need a faster route. The antenatal plan should extend beyond delivery, naming early postnatal contacts, sleep support, prescribing responsibility and urgent warning signs.
Key points
Depression and anxiety disorders are under-recognised in pregnancy; ask within a general, non-judgemental conversation rather than waiting for visible distress.
Explore low mood and lost interest, GAD-2 symptoms, panic, obsessions, compulsions, trauma, social fear, tokophobia and illness anxiety because 'worry' is not one diagnosis.
A positive identification question or questionnaire is an invitation to full assessment, not a diagnosis or a suicide-risk score.
Assess suicide, self-neglect, substance use, domestic abuse, obstetric health, bipolarity, psychosis, eating, sleep, support and ability to engage with maternity care.
For persistent subthreshold symptoms or mild-to-moderate depression, NICE says to consider facilitated self-help.
For moderate or severe depression, consider high-intensity psychological therapy, an antidepressant after informed preference-based discussion, or combination treatment after limited response to either alone.
For an anxiety disorder, offer the disorder-specific low- or high-intensity psychological intervention; PTSD and social anxiety begin with high-intensity treatment.
If a referred person has a known or suspected perinatal mental-health problem, NICE expects treatment assessment within two weeks and psychological intervention within one month of initial assessment.
Aetiology
01
Prior vulnerability
Previous depression, anxiety, trauma, bipolar illness or severe perinatal episodes interact with the physiological and social changes of pregnancy to increase recurrence risk.
02
Pregnancy-specific stress
Hyperemesis, pain, fetal uncertainty, previous loss, tokophobia, medical complications and altered body autonomy can precipitate or maintain symptoms.
03
Social adversity
Domestic abuse, poverty, racism, insecure housing, migration stress, isolation and caring burden can create persistent threat while restricting access to treatment.
04
Treatment disruption
Abrupt medication cessation, withdrawal symptoms, loss of established therapy or fragmented handover may convert a manageable vulnerability into an active episode.
Pathophysiology
1
Stress regulation
Sustained threat and uncertainty alter arousal, attention and sleep, reinforcing worry and reducing the cognitive flexibility needed to update feared predictions.
2
Reward and avoidance cycles
Withdrawal from valued activity reduces reinforcement in depression, while avoidance brings short-term anxiety relief that strengthens future fear and restriction.
3
Physiological transition
Endocrine, immune, sleep and pharmacokinetic changes can influence symptom expression and drug exposure, but no single pregnancy hormone explains an individual disorder.
4
Cognitive meaning
Responsibility beliefs, shame, catastrophic interpretations and trauma memories can magnify ordinary bodily sensations or intrusive thoughts into persistent distress.
Clinical features and red flags
Depressive cognitive pattern
Persistent hopelessness, loss of pleasure, excessive guilt, worthlessness, slowed thinking and suicidal ideas distinguish a depressive syndrome from isolated pregnancy fatigue.
Recurrent intrusive thoughts that are unwanted, frightening and resisted, with checking or avoidance, favour OCD; assess insight and any intent rather than equating thought with action.
Trauma and childbirth fear
Nightmares, flashbacks, avoidance, hyperarousal or extreme childbirth fear may follow prior loss, assault, medical trauma or difficult maternity experiences and need specific formulation.
Bipolar warning pattern
Episodic reduced need for sleep, unusually increased energy, pressured speech, grandiosity or disinhibition indicates a different treatment pathway and higher postpartum risk.
Functional severity
Missed antenatal care, inability to eat, prolonged insomnia, medication neglect, isolation or loss of self-care can demonstrate severity even when a questionnaire score seems modest.
Red flags requiring action
A suicide plan, recent high-lethality self-harm, psychotic depression or stated inability to remain safe needs immediate senior mental-health assessment.
Investigations
01Clinical diagnostic interviewFirst step
Why
Characterise symptom clusters, duration, impairment, previous episodes, mania, psychosis, trauma, substance use and treatment response.
Interpretation and limitations
Depression or a defined anxiety disorder is diagnosed clinically; normal pregnancy symptoms require context, while bipolar features redirect antidepressant decisions.
02Direct safety and safeguarding assessment
Why
Clarify suicidal thinking, self-harm, self-neglect, risk to others, domestic abuse, coercion and access to lethal means.
Interpretation and limitations
Formulate current drivers, intent, capability, protective support and foreseeable change; low questionnaire scores do not override concerning narrative evidence.
03EPDS, PHQ-9 or GAD-7
Why
Support fuller assessment after identification questions and provide a shared baseline for symptom monitoring.
Interpretation and limitations
Use validated scales as adjuncts; language, literacy, trauma and fear of disclosure can affect responses, and no cut-off proves safety.
04Targeted physical assessment
Why
Investigate anaemia, thyroid disease, hyperemesis, infection, pain, sleep disorder or medicine and substance effects when suggested clinically.
Interpretation and limitations
Select examination and tests from symptoms and gestation; psychiatric and physical illness may coexist rather than exclude one another.
Differential diagnosis
01
Bipolar disorder
Past elation, reduced sleep need, grandiosity, episodic overactivity or antidepressant activation suggests bipolarity and changes both urgency and pharmacological strategy.
02
Physical pregnancy disorder
Anaemia, thyroid disease, hyperemesis, infection, hypertensive disease, pain or sleep-disordered breathing may resemble or worsen psychiatric symptoms.
03
Expected transient worry
Proportionate concern that remains flexible and does not cause sustained impairment differs from pervasive, uncontrollable fear or a depressive syndrome.
04
Substance or medicine effect
Caffeine, alcohol, stimulants, steroids, antiemetics, withdrawal and non-prescribed substances can cause anxiety, insomnia, agitation or mood change.
05
Psychosis or delirium
Delusions, hallucinations, marked disorganisation, fluctuating attention or confusion require urgent assessment and investigation beyond a routine anxiety formulation.
Management
01RecognitionMove from screen to formulationFirst stepIdentification questions, a score, observed distress or clinical concern suggests depression or anxiety during pregnancy.+
1Clarify the complete syndrome, duration, function, gestation and the person's explanation of what is happening.
3Agree diagnosis or working formulation, urgency, monitoring measures and which maternity, primary-care or mental-health service owns each action.
02Psychological careMatch intensity to disorder and severityAntenatal depression or anxiety is present without an immediate emergency requiring crisis care.+
1Consider facilitated self-help for persistent subthreshold or mild-to-moderate depression and for subthreshold anxiety using the specified supported CBT materials.
Complications
01
Suicide and self-neglect
Hopelessness, agitation, isolation and impaired self-care can threaten the pregnant person directly and disrupt nutrition, medication and maternity engagement.
02
Obstetric disengagement
Fear, avoidance, shame or coercion may lead to missed appointments and delayed presentation with physical complications that require coordinated outreach.
03
Substance-related harm
Alcohol, nicotine, sedatives or illicit drugs may be used to manage distress, introducing dependence, overdose and fetal or neonatal risks.
04
Postnatal escalation
An unresolved antenatal episode, severe sleep loss and treatment discontinuity can worsen after birth, particularly when bipolar illness was not recognised.
05
Iatrogenic fear
Alarmist counselling or fragmented prescribing can provoke abrupt withdrawal, concealment of symptoms and avoidance of otherwise beneficial care.
Monitoring and follow-up
Agree the first review according to severity and treatment; after medicine initiation or change, assess activation, agitation, sleep, self-harm and suicide early rather than waiting for routine antenatal follow-up.
Repeat an agreed symptom measure alongside nutrition, self-care, work or caregiving function, appointment attendance and personally important goals.
Ask about hypomania, psychosis, alcohol or drug use, domestic abuse and new obstetric symptoms whenever the clinical picture shifts.
Check that psychological treatment begins within the recommended perinatal timeframe after assessment and address language, transport, childcare, digital or trauma-related barriers.
For antidepressants, review adherence, dose, benefit, adverse effects and interactions; record the discussion of late-pregnancy neonatal and haemorrhage considerations without instituting an automatic pre-delivery taper.
Before birth, circulate the postpartum contact, sleep, feeding, prescribing and relapse plan to the person, GP, maternity service and relevant mental-health team.
Special situations
Somatic overlap needs context
Fatigue and broken sleep can be physiological, but pervasive anhedonia, hopelessness, guilt and functional decline make depressive illness more likely.
Intrusion is not intention
An ego-dystonic image that horrifies the person differs from a desired or commanded act, although both deserve a careful safety assessment.
Screening invites disclosure
The value of a brief question lies in opening a fuller conversation; its score cannot substitute for diagnosis or risk formulation.
Birth fear has causes
Tokophobia may reflect trauma, pain fears, loss of control or prior discriminatory care, so listening and obstetric collaboration precede procedural negotiation.
Postpartum starts antenatally
Medication restart, sleep protection and emergency contacts should be decided before labour, when cognitive load and service boundaries are easier to manage.
Common pitfalls
01
Dismissing persistent hopelessness and loss of function as ordinary pregnancy tiredness.
02
Labelling every intrusive image as intent to harm, which can intensify shame and suppress future disclosure.
03
Using EPDS, PHQ-9 or GAD-7 as a stand-alone diagnosis or a prediction that suicide will not occur.
04
Starting an antidepressant without checking for previous mania, hypomania or postpartum psychosis.
05
Automatically discontinuing a successful medicine after conception without weighing withdrawal and recurrence.
06
Treating domestic abuse, financial hardship or unsafe housing as background details rather than active maintaining and safety factors.
Do not stop an effective antidepressant abruptly after pregnancy is discovered; compare relapse, withdrawal, gestational stage and medicine-specific risks.
Plan postnatal monitoring before birth because sleep loss and service transitions can reveal or amplify severe illness.
Decreased need for sleep with elation, grandiosity, disinhibition or psychosis suggests mania rather than uncomplicated anxiety and makes antidepressant escalation unsafe.
Food or fluid refusal, marked weight loss, dehydration, severe insomnia or inability to attend essential antenatal care indicates serious functional compromise.
Fear of a partner, unexplained injuries, surveillance of communication, reproductive coercion or being prevented from speaking alone requires private domestic-abuse and safeguarding enquiry.
Vaginal bleeding, severe abdominal pain, collapse, seizures, severe headache, visual symptoms or reduced fetal movements must not be attributed to anxiety without maternity assessment.
05Obstetric and medication review
Why
Establish gestation, pregnancy complications, fetal concerns, actual exposures, adherence and relevant interactions.
Interpretation and limitations
The stage of pregnancy and planned delivery inform risk discussion and neonatal observation but do not dictate automatic withdrawal of effective treatment.
2
For moderate-to-severe depression consider high-intensity therapy, medication after informed preference-sensitive discussion, or combined care after limited response; use disorder-specific therapy for anxiety.
3EscalationTrack attendance, symptom change, functioning and safety; escalate promptly if low-intensity care is ineffective, noting the two-week reassessment point in the perinatal anxiety recommendation.
03Medication decisionPreserve benefit while reducing avoidable exposureSymptoms are severe, psychological treatment is declined or insufficient, or a previously effective antidepressant is already being taken.+
1Discuss previous response, withdrawal, relapse, gestational stage, fetal and neonatal evidence, bleeding risk, alternatives and the person's informed preference.
2Choose the lowest-risk suitable drug and lowest effective dose, favouring one medicine where possible; titrate by the licensed adult regimen and clinical response.
3Monitor activation, suicidality, adherence and physical effects early, and communicate late-pregnancy exposure and the newborn observation plan to maternity care.
Key medicines and prescribing safety1 treatment · regimens, roles and cautions+
An SSRI can be considered for moderate or severe antenatal depression after an individual discussion, especially when it previously worked, high-intensity therapy is declined or unavailable, or symptoms have not responded. NICE does not name one universally preferred antidepressant for pregnancy.
Sertraline example regimen
For adult major depression, the SmPC starting dose is 50 mg orally once daily. If response is insufficient, increase in 50 mg steps no more often than weekly to a maximum of 200 mg daily; maintain the lowest effective dose and taper rather than stop abruptly.
Check bipolar features, suicidality, hyponatraemia risk, bleeding medicines and serotonergic interactions. Discuss uncertain reproductive evidence, possible neonatal adaptation symptoms and PPHN signal with late exposure, and the small increased postpartum-haemorrhage risk with SSRI or SNRI use in the month before delivery.